{"id":"W2763742548","doi":"10.1093/annonc/mdx440.008","title":"MONARCH 3: Abemaciclib as initial therapy for patients with HR+/HER2- advanced breast cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham","funders":"","keywords":"Medicine; Internal medicine; Fulvestrant; Breast cancer; Metastatic breast cancer; Oncology; Hazard ratio; Letrozole; Anastrozole; Aromatase inhibitor; Tolerability; Cancer; Adverse effect; Estrogen receptor; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001341886,0.0002110795,0.0005933876,0.00007805915,0.0001909144,0.00001082282,0.0002651799,0.0001378756,0.0002329837],"category_scores_gemma":[0.00006859337,0.0001598617,0.0001122241,0.00005474322,0.0004563979,0.0002404933,0.00004794064,0.0001551896,0.000007987154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006147865,"about_ca_system_score_gemma":0.0004554594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001886765,"about_ca_topic_score_gemma":0.00006076313,"domain_scores_codex":[0.9986683,0.00003461873,0.0002873563,0.0003371529,0.0002505994,0.0004220072],"domain_scores_gemma":[0.997819,0.0001232505,0.0004567907,0.0005493736,0.0009056146,0.0001459791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02796583,0.0008945694,0.07376616,0.0000592677,0.0003084221,0.00001548926,0.0003483929,0.00001521666,0.0009073412,0.0001852911,0.0002907075,0.8952433],"study_design_scores_gemma":[0.02467081,0.0153605,0.7958494,0.0002320038,0.00006325604,0.0000599913,0.0001280613,0.00001291298,0.01044475,0.001918176,0.150939,0.0003211755],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981782,0.0005692566,0.00008566192,0.01317184,0.0002859694,0.001084228,0.0002340225,0.00003453218,0.002752482],"genre_scores_gemma":[0.9938293,0.0006746919,0.001512008,0.002877653,0.0003238357,0.0003678883,0.0000313252,0.00005335519,0.0003299701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8949221,"threshold_uncertainty_score":0.651897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07265391653121518,"score_gpt":0.4623746340739686,"score_spread":0.3897207175427534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}